Operating Expenses Veränderung
Abbvie ABBV:US $ 11288M 2467M
Amgen AMGN:US $ 4.42B 680M
AstraZeneca AZN:LN 840.42B 39.99B
Astrazeneca AZN:US 10.23B 280M
Biogen BIIB:US $ 2648.2M 727.1M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Canopy Growth Corp WEED:CN C$ 1.95B 1.3B
Catalent CTLT:US $ 1.07B 5M
Corcept Therapeutics CORT:US $ 71.95M 5.04M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 584.8B 95.1B
Glaxosmithkline GSK:US 5.85B 1.13B
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Johnson & Johnson JNJ:US $ 18.18B 616M
Lannett LCI:US $ 152.15M 51.71M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Prestige Brands PBH:US $ 190.04M 534K
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
Valeant Pharmaceuticals VRX:CN C$ 2.18B 546.23M
Zoetis ZTS:US $ 1.38B 123M



Novartis Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.